1 Bantle, J. P. Is fructose the optimal low glycemic index sweetener? Nestle Nutr Workshop Ser Clin Perform Programme 11, 83-95 (2006).
2 Bray, G. A., Nielsen, S. J. & Popkin, B. M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79, 537-543 (2004).
3 Taskinen, M. R. et al. Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity. J Intern Med 282, 187-201 (2017).
4 Jalal, D. I., Smits, G., Johnson, R. J. & Chonchol, M. Increased fructose associates with elevated blood pressure. J Am Soc Nephrol 21, 1543-1549 (2010).
5 Angelopoulos, T. J. et al. The effect of high-fructose corn syrup consumption on triglycerides and uric acid. J Nutr 139, 1242S-1245S (2009).
6 Stanhope, K. L. et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119, 1322-1334 (2009).
7 Nakagawa, T. et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290, F625-631 (2006).
8 Perez-Pozo, S. E. et al. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: Role of uric acid in the hypertensive response. Int J Obes (Lond) 34, 454-461 (2010).
9 Brown, C. M., Dulloo, A. G., Yepuri, G. & Montani, J. P. Fructose ingestion acutely elevates blood pressure in healthy young humans. Am J Physiol Regul Integr Comp Physiol 294, R730-737 (2008).
10 Chen, L. et al. Reducing consumption of sugar-sweetened beverages is associated with reduced blood pressure: A prospective study among United States adults. Circulation 121, 2398-2406 (2010).
11 Cirillo, P. et al. Ketohexokinase-dependent metabolism of fructose induces proinflammatory mediators in proximal tubular cells. J Am Soc Nephrol 20, 545-553 (2009).
12 Nakayama, T. et al. Dietary fructose causes tubulointerstitial injury in the normal rat kidney. Am J Physiol Renal Physiol 298, F712-720 (2010).
13 Aoyama, M. et al. Fructose induces tubulointerstitial injury in the kidney of mice. Biochem Biophys Res Commun 419, 244-249 (2012).
14 Gersch, M. S. et al. Fructose, but not dextrose, accelerates the progression of chronic kidney disease. Am J Physiol Renal Physiol 293, F1256-1261 (2007).
15 Brymora, A. et al. Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease. Nephrol Dial Transplant (2011).
16 Gaby, A. R. Adverse effects of dietary fructose. Altern Med Rev 10, 294-306 (2005).
17 Jang, C. et al. The Small intestine converts dietary fructose into glucose and organic acids. Cell Metab 27, 351-361 e353 (2018).
18 Gordish, K. L., Kassem, K. M., Ortiz, P. A. & Beierwaltes, W. H. Moderate (20%) fructose-enriched diet stimulates salt-sensitive hypertension with increased salt retention and decreased renal nitric oxide. Physiol Rep 5 (2017).
19 Naito, Y. et al. Iron-restricted pair-feeding affects renal damage in rats with chronic kidney disease. PLOS ONE 12, e0172157 (2017).
20 Takayanagi, K. et al. Down-regulation of transient receptor potential (TRP) M6 channel as a cause of hypermagnesiuric hypomagnesemia in obese type-2 diabetic rats. Am J Physiol, Renal Physiol 308, F1386-1397 (2015).
21 Asakura, J. et al. Renoprotective effect of pioglitazone by the prevention of glomerular hyperfiltration through the possible restoration of altered macula densa signaling in rats with type-2 diabetic nephropathy. Exp Nephrol 122, 83-94 (2013).
22 Queiroz-Leite, G. D. et al. Fructose acutely stimulates NHE3 activity in kidney proximal tubule. Kidney Blood Press Res 36, 320-334 (2012).
23 Gonzalez-Vicente, A. et al. Dietary fructose enhances the ability of low concentrations of angiotensin II to stimulate proximal tubule Na⁺ reabsorption. Nutrients 9 (2017).
24 Hayasaki, T. et al. Fructose increases the activity of sodium hydrogen exchanger in renal proximal tubules that is dependent on ketohexokinase. J Nutr Biochem 71, 54-62 (2019).
25 Nishimoto, Y., Tomida, T., Matsui, H., Ito, T. & Okumura, K. Decrease in renal medullary endothelial nitric oxide synthase of fructose-fed, salt-sensitive hypertensive rats. Hypertension 40, 190-194 (2002).
26 Guo, Q. et al. Losartan modulates muscular capillary density and reverses thiazide diuretic-exacerbated insulin resistance in fructose-fed rats. Hypertens Res 35, 48-54 (2012).
27 Oudot, C., Lajoix, A. D., Jover, B. & Rugale, C. Dietary sodium restriction prevents kidney damage in high fructose-fed rats. Kidney Int 83, 674-683 (2013).
28 Singh, A. K. et al. Fructose-induced hypertension: essential role of chloride and fructose absorbing transporters PAT1 and Glut5. Kidney Int 74, 438-447 (2008).
29 Thiesson, H. C. et al. Renal sodium retention in cirrhotic rats depends on glucocorticoid-mediated activation of mineralocorticoid receptor due to decreased renal 11beta-HSD-2 activity. Am J Physiol Regul Integr Comp Physiol 292, R625-636 (2007).
30 Sanchez-Lozada, L. G. et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 292, F423-429 (2007).
31 Hu, G., Xu, L., Ma, Y., Kohzuki, M. & Ito, O. Chronic exercise provides renal-protective effects with upregulation of fatty acid oxidation in the kidney of high fructose-fed rats. Am J Physiol Renal Physiol 318, F826-F834 (2020).
32 Sugawara-Yokoo, M., Suzuki, T., Matsuzaki, T., Naruse, T. & Takata, K. Presence of fructose transporter GLUT5 in the S3 proximal tubules in the rat kidney. Kidney Int 56, 1022-1028 (1999).
33 Diggle, C. P. et al. Both isoforms of ketohexokinase are dispensable for normal growth and development. Physiol Genomics 42A, 235-243 (2010).
34 Dekker, M. J., Su, Q., Baker, C., Rutledge, A. C. & Adeli, K. Fructose: A highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 299, E685-694 (2010).
35 Wood, I. S. & Trayhurn, P. Glucose transporters (GLUT and SGLT): Expanded families of sugar transport proteins. Br J Nutr 89, 3-9 (2003).
36 Grempler, R. et al. Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporter. FEBS Lett 586, 248-253 (2012).
37 Fukuzawa, T. et al. SGLT5 reabsorbs fructose in the kidney but its deficiency paradoxically exacerbates hepatic steatosis induced by fructose. PLOS ONE 8, e56681 (2013).
38 Gonzalez-Vicente, A. et al. Fructose reabsorption by rat proximal tubules: Role of Na(+)-linked cotransporters and the effect of dietary fructose. Am J Physiol Renal Physiol 316, F473-F480 (2019).
39 Ghezzi, C. et al. Fingerprints of hSGLT5 sugar and cation selectivity. Am J Physiol Cell Physiol 306, C864-870 (2014).